The Working Table for the internationalisation of industries in the biotechnology sector set up by Italian Minister of Foreign Affairs Antonio Tajani gets underway today – a first concrete follow-up to the conference on emerging biotechnologies held at the Italian Ministry of Foreign Affairs on 14 November.
“With more than 800 companies, 14 thousand employees, over 13 billion in turnover and a strong R&D component, the Italian biotechnology sector is experiencing a phase of remarkable development and constitutes an important driving force for growth in sectors with increasingly high added value”, said Minister Tajani.
The establishment of the round table, which is called upon to formulate strategies and recommendations on the internationalisation of players active in the field of biotechnology in order to strengthen the entire national sector, “reflects the attention that the Italian government attaches to the international development of innovative supply chains and emerging technologies, within the framework of Growth Diplomacy”, according to Tajani.
The table will be attended by representatives of institutions, research centres, companies, trade associations and the financial world. Among others, as moderator, Pierluigi Paracchi, CEO of Genenta and member of the Executive Committee of Federchimica-Assobiotec; Pierluigi Petrone, Vice President of Farmaindustria; Giovanni Caforio, Executive Chairman of Bristol Myers Squibb; Maria Cristina Porta, General Director of the ENEA Tech and Biomedical Foundation; Giuseppe Gigli, Director of the CNR-Nanotec Institute of Nanotechnology; Rino Rappuoli, Scientific Director of Fondazione Biotecnopolo di Siena; Gianmario Verona, President of Human Technolpole. Representatives of the Italian Ministry of Enterprises and Made in Italy, the Italian Ministry of University and Research and the ICE Agency will also be attending.
